OOIR: Observatory of International Research

Papers

(The median citation count of New England Journal of Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Screening for Prostate Cancer	4941
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure	2821
Case 18-2025: A 63-Year-Old Woman with Dyspnea on Exertion	2543
A Modern Therapy for an Ancient Disease	2355
Hiding in Plain Sight	1880
Rethinking Shadowing for Aspiring Physicians	1781
A Trial of Trimethoprim–Sulfamethoxazole in Pregnancy to Improve Birth Outcomes	1677
Redefining Lung Cancer Therapy — A Long-Awaited Shift in Strategy	1572
SENIOR-RITA — Is It All about Angiography?	1484
Cerebral Embolic Protection during TAVI	1114
Listening and Responding to Community Voices — The Community Wellness HUB	1091
Automated Insulin Pump in Type 2 Diabetes	1069
A Swell Diagnosis	1041
Postacute Sequelae of SARS-CoV-2 Infection in Several Eras	1031
Race-Based Diagnosis, Part 1 — ITT Episode 33	1010
Investigating Injustices in the Journal ’s History, Part 2	1003
Hemotympanum with a Basilar Skull Fracture	1000
Secondary Hypertrophic Osteoarthropathy	986
Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors	898
Testing for Arginine Vasopressin Deficiency	877
Case 40-2022: A 38-Year-Old Man with Exertional Chest Discomfort	875
The Muffin Question	874
Bilothorax	868
Audio Interview: Assessing Bivalent Vaccines against Covid-19	866
Nationwide, Couple-Based Genetic Carrier Screening	862

Poet as Patient	859
Liver Transplantation for Mahvash Disease, an Inborn Error of Metabolism	844
Adrenal Involvement in Disseminated Histoplasmosis	839
Multicentric Reticulohistiocytosis	838
Black Dot Tinea Capitis	828
Timing Is Everything — Evidence for When to Perform Complete Revascularization in STEMI	819
Convalescent Rash of Dengue	809
Prolonging Cellular Life after Hypoxic Death	779
Cholelithiasis, Cholecystitis, and Choledocholithiasis	775
Gazing into a Crystal Ball	757
Breaking the Sacred Promise	753
Pistachio Ice Cream	742
Minocycline-Induced Hyperpigmentation	740
Bismuth Subsalicylate Poisoning	736
A Case of Cervical Ectopic Pregnancy after the Dobbs Decision	735
Paget’s Disease of the Breast	728
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia	724
From the Eyeball Test to the Algorithm — Quality of Life, Disability Status, and Clinical Decision Making in Surgery	715
Modifiable Risk Factors and Cardiovascular Outcomes	714
Preparing for the Next Pandemic — Expanding and Coordinating Global Regulatory Capacity	705
Genetic Variation in Clinical Cohorts	700
Striking a Balance — Advancing Physician Collective-Bargaining Rights and Patient Protections	697
Gantenerumab in Early Alzheimer’s Disease	688
Number Needed to Treat	686
Transformative Research in Cystic Fibrosis	683
Monoclonal Antibodies for Malaria	681
Selective Digestive Decontamination — Finding the Way Forward	664
Zilebesiran for Hypertension	658
How to Save a Life	658
Perioperative Durvalumab in Bladder Cancer	644
Tenecteplase for Stroke — Opening the Window?	637
Exclusion of Elective Care from Hospital Financial Assistance Policies — Arresting a Troubling Development	615
Spontaneous Intracranial Hypotension	613
Malnutrition in Adults	604
U.S. Law and Discrimination in Health Care	600
Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents	570
Meet the Equation	568
HFpEF Explained — Prevalence, New Advances, and How to Diagnose	546
Overcoming Resistance — Omission of Radiotherapy for Low-Risk Breast Cancer	539
War and Famine	536
Effect of a Reduced PCV10 Dose Schedule on Pneumococcal Carriage in Vietnam	533
Mucosal IgA against SARS-CoV-2 Omicron Infection	526
Left Atrial Appendage Closure — Another Overused Method in Cardiology?	526
Nutritional Support for Moderate-to-Late–Preterm Infants — A Randomized Trial	525
Targeting CSF1R in Chronic GVHD — Lessons in Translation	525
Threatening the Future of Global Health — NIH Policy Changes on International Research Collaborations	523
Carrier	520
Permethrin-Treated Baby Wraps for the Prevention of Malaria	494
Early Active Mobilization during Mechanical Ventilation in the ICU	494
Optical Coherence Tomography and Eye Care	487

A Threat to Evidence-Based Vaccine Policy and Public Health Security at the FDA	486
Kidney Transplantation after Clearing Anti-HLA Antibodies with CD19 CAR T Cells	485
Smallpox at the Siege of Boston, November 1775–March 1776	484
Debating Race and the Diagnosis of Anemia — How Medicine Moved Away from Race-Based Standards	482
Turning CMS into a Health Technology Assessment Organization	480
Haloperidol for the Treatment of Delirium in ICU Patients	478
Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda	476
More Options for Gene Editing in Hemoglobinopathies	474
Out of Pocket Getting Out of Hand — Reducing the Financial Toxicity of Rapidly Approved Drugs	474
Kidney Injury and Hair-Straightening Products Containing Glyoxylic Acid	466
Psychosocial Functioning in Transgender Youth after 2 Years of Hormones	466
Ensartinib in Resected ALK -Positive Non–Small-Cell Lung Cancer	455
Childhood Risk Factors and Adult Cardiovascular Events	453
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy	452
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial	448
Use of Wastewater for Mpox Outbreak Surveillance in California	447
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk	446
Hypothermia or Machine Perfusion in Kidney Donors	445
Navigating and Communicating about Serious Illness and End of Life	441
Evidence-Based Work Design — Bridging the Divide	435
Ten Years of Incidental, Secondary, and Actionable Findings	434
Monoclonal Antibodies in the Pathogenesis of Heparin-Induced Thrombocytopenia	433
Daraxonrasib in Advanced RAS -Mutated Pancreatic Cancer	429
Ménétrier’s Disease	427
Bronchiectasis — A Clinical Review	423
Understanding How Aspirin Prevents Metastasis	423
Navigating and Communicating about Serious Illness and End of Life	421
Reteplase versus Alteplase for Acute Ischemic Stroke	421
T-Cell Engager–Mediated HLA Antibody Depletion before Kidney Transplantation	418
Middle Meningeal Artery Embolization for Subdural Hematoma	418
Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer	416
Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD	415
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia	414
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia	409
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B	409
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype	404
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes	399
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer	395
Periprosthetic Joint Infection	394
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma	391
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer	387
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma	387
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction	385
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts	380
Clinical Characteristics of Patients Infected with Bundibugyo Virus, DRC 2026	378
A Tale of Two Diseases	377
Functional Dyspepsia	375
Integration of Tobacco-Cessation Interventions into Tuberculosis and HIV Care	374
Vocal-Cord Polyp Causing Airway Obstruction	372
Amivantamab–Lazertinib in EGFR -Mutated Advanced NSCLC	372
Invasive Strategy for Older Patients with MI	366
Elective Cesarean Section for Maternal Preference	364
Covid-19 Surveillance Testing in Nursing Homes	358
Leveraging School Systems as Data Partners to Advance Health Equity	357
Necrolytic Migratory Erythema	356
Closing the Evidence Gap for Drugs in Children — Measures to Strengthen the Pediatric Research Equity Act	355
Cholesterol Pericarditis	352
Case 38-2024: A 22-Year-Old Woman with Headache, Fever, and Respiratory Failure	348
Case 5-2023: A 67-Year-Old Man with Interstitial Lung Disease, Fever, and Myalgias	347
Audio Interview: Rolling Out New Covid-19 Vaccines	347
Crinecerfont in Adult Congenital Adrenal Hyperplasia	347
Personality Disorders	347
HIV Prevention and the 340B Drug Pricing Program	346
Medication for Gastroesophageal Reflux Disease in Infants	344
Broken Both Ways	341
Convalescent Plasma for Covid-19–Induced ARDS	337
What We Don’t Know about School Shooter Drills	336
Case 21-2023: A 61-Year-Old Man with Eyelid Swelling	335
Intravenous Amino Acids and Kidney Protection	334
Case 26-2022: A 48-Year-Old Woman with Cystic Lung Disease	334
Felzartamab in Antibody-Mediated Rejection	334
Diagnostic Aspirations	333
Audio Interview: Ending the Covid-19 Public Health Emergency	332
End of a Declared Public Health Emergency — Implications for U.S. Emergency Use Authorizations	328
PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer	328
Guilty	328
Case 39-2023: A 43-Year-Old Woman with Chronic Diarrhea, Hair Loss, and Nail and Skin Changes	327
Audio Interview: Ending the Covid-19 Emergency	324
Chylothorax	324
FINEARTS-HF — The Latest Masterpiece for MRAs in Heart Failure	322

Ondansetron after ED Visits in Children with Gastroenteritis	322
Academic Freedom in America — In Support of Institutional Voices	322
Neurovascular Complications of Iatrogenic Fusarium solani Meningitis	321
Laryngeal Candidiasis	320
Genetically Modified Porcine-to-Human Cardiac Xenotransplantation	317
Can AI Solve Primary Care?	314
Water-Based and Waterless Surgical Scrub Techniques	310
The Death of an Unlikable Man	310
A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?	310
Pegylated Interferon Lambda for Covid-19	310
Helicobacter pylori , Homologous-Recombination Genes, and Gastric Cancer	308
Unpacking the Ordinary	307
Pretomanid in the Treatment of Patients with Tuberculosis in the United States	305
Hospital Problems	303
Making Long-Term Oxygen Therapy Less Burdensome	302
Atrial Fibrillation — What Is It and How Is It Treated?	301
Criminalizing Homelessness — The Grants Pass, Oregon, Supreme Court Case	299
Genital Herpes Zoster	299
Postherpetic Abdominal Pseudohernia	297
Gustatory Hyperhidrosis after Parotid Surgery	294
Gastric Syphilis	294
Public Health’s Role in a Post- Dobbs World — The New York City Abortion Access Hub	293
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6	291
Occupational Health and Safety on the Chopping Block — What’s at Stake?	289
Extending Cancer Survival with Exercise — Time for Oncology to Act	288
Neovascularization of the Disk in Proliferative Diabetic Retinopathy	286
Moving the Needle on Alzheimer’s Disease with an Anti-Oligomer Antibody	284
Global Cholera-Control Efforts — Progress and Remaining Challenges	284
Immune Checkpoint Inhibitors — The Need for Innovation	284
Guidance on Energy and Macronutrients across the Life Span	283
Mycoplasma-Induced Rash and Mucositis	282
Medication-Associated Diethylene Glycol Mass Poisoning — A Preventable Cause of Illness and Death	281
“Putting America First” — Undermining Health for Populations at Home and Abroad	280
Small Step or Giant Leap? Expanding the Acute Stroke Thrombolysis Window to 24 Hours	277
Disappearing Data at the U.S. Federal Government	276
Immunogenicity and Safety of vYF, a Yellow Fever Vaccine — A Phase 2 Trial	276
SGLT2 Inhibitors and False Positive Toxicology Tests	275
Increasing Firearm-Related Deaths among U.S. Black Rural Youths	274
NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction	274
The Risks of Normalizing Parental Vaccine Hesitancy	274
Retraction: Bronchial Casts from Inhalation of Forest-Fire Smoke. N Engl J Med 2026;394:1634.	272
Autoantibodies Targeting Nephrin in Podocytopathies	272
New Perioperative Strategy in Gastric Cancer	272
Trends in Youth-Onset Type 2 Diabetes, 2013–2024	270
Targeting Lipoprotein(a) — the Next Frontier in Cardiovascular Disease	269
Patient-Driven Care in Psychedelic Therapy	269
Advanced HIV as a Neglected Disease	265
Fibromyalgia	265
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction	264
Transforming Management of Opioid Use Disorder with Universal Treatment	263
Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases	263
Mucormycosis	262
Cardiac Implantable Electronic Devices	262
Ultraprocessed Food on an Ultrafast Track	261
Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas	260
Compared with What? Measuring AI against the Health Care We Have	260
Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction	260
Focused Cardiac Ultrasonography for Right Ventricular Size and Systolic Function	259
Methylprednisolone for Heart Surgery in Infants — A Randomized, Controlled Trial	258
Fulminant Viral Myocarditis Associated with Thogotovirus	258
Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone	256
Emodepside for Trichuris trichiura and Hookworm Infection	256
A Zoonotic Henipavirus in Febrile Patients in China	255
Bivalent Covid-19 Vaccines — A Cautionary Tale	254
Monkeypox	254
Tuberculous Meningitis — New Approaches Needed	253
Transfusion Strategy in Myocardial Infarction and Anemia	251
Selpercatinib in Early-Stage RET Fusion–Positive Non–Small-Cell Lung Cancer	250
Cardiovascular Risk Factors — Hypertension	250
Japanese Spotted Fever	249
Phase 3 Trial of Weekly Oral Islatravir–Lenacapavir for HIV-1 Treatment	249
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes	249
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy	248
Artificial Intelligence in Medicine	247
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction	245
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma	245
A Dual-Chamber Leadless Pacemaker	245
Trials for Managing Acute Pain — A Clinically Meaningful Small Effect Size?	244
Behçet’s Syndrome	243
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity	242
Expect With Me — Group Prenatal Care to Reduce Disparities	241
Autoantibodies Targeting Nephrin in Podocytopathies	240
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension	237
Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis	237
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma	237
Dengue Suppression by Male Wolbachia-Infected Mosquitoes	236
Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial	236
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis	236
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation	235
A Preview of the Dangerous Future of Abortion Bans — Texas Senate Bill 8	234
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation	234
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults	229
Aspiration Thrombectomy for Coronary Stent Thrombosis	229
Case 1-2023: A 49-Year-Old Man with Hypokalemia and Paranoia	228
Loosening the Shackles of Depression	227